Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deuterated water labeling of specialized T-cell subsets
NL-OMON56738Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2025
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of deuterated water, hepatitis A + hepatitis B vaccine, Boostrix Polio and M-M-R II (2 cohorts), sponsored by University Medical Center Utrecht. Primary endpoints: Turnover rate of antigen-specific cells and Turnover rate of functional T-cell subsets. Started Apr 2025; status: recruiting.
02
Drugs
deuterated waterhepatitis A + hepatitis B vaccineBoostrix PolioM-M-R II
Beyond the preview
Go deeper on NL-OMON56738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56738.